Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Levosimendan: A New Therapeutic Option in the Treatment of Primary Graft Dysfunction After Heart Transplantation
The Journal of Heart and Lung Transplantation, 05/12/09
Weis F et al. - The patients showed a rapid reduction of the doses of inotropic drugs, and no patient needed mechanical support. Levosimendan may be a useful, adjunctive inotropic drug in the treatment of patients with primary graft dysfunction after heart transplantation.
Related Articles
The Influence of the Recipients Body Weight on the Probability to Obtain a Heart Transplant--POLKARD HF Registry
Transplantation Proceedings, 11/16/09
Relevance Score: 70%
Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 70%
Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 70%
Simultaneous Heart and Kidney Transplantation After Bridging With The CardioWest Total Artificial Heart
Annals of Thoracic Surgery, 10/13/09
Relevance Score: 70%
Parallel Application of Extracorporeal Membrane Oxygenation and the CardioWest Total Artificial Heart as a Bridge to Transplant
Annals of Thoracic Surgery, 10/30/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clopidogrel Hypersensitivity: A Novel Multi-Day Outpatient Oral Desensitization Regimen
Annals of Pharmacotherapy, 12/16/09
Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients
The American Journal of Cardiology, 12/16/09
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Today in Transplant/Augmentation...keeping you current
Receive free subspecialty "5-minute updates" via email
Heart Transplantation in a Low-Organ-Donation Environment: A Single Center Experience
Transplantation Proceedings, 12/16/09
Validation of Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure During the First Year After Heart Transplantation
Transplantation Proceedings, 12/16/09
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis
Transfusion, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


